These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29972745)

  • 41. Buprenorphine: effective treatment of opioid addiction starts in the office.
    Fiellin DA
    Am Fam Physician; 2006 May; 73(9):1513-4. PubMed ID: 16719242
    [No Abstract]   [Full Text] [Related]  

  • 42. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 43. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 44. Update on pharmacotherapy for treatment of opioid use disorder.
    Ayanga D; Shorter D; Kosten TR
    Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Naltrexone and opiate substitutive treatment].
    Dupouy J; Poutrain JC; Lapeyre-Mestre M
    Therapie; 2011; 66(6):549-52. PubMed ID: 22691393
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacotherapy for Substance Use Disorders.
    Klein JW
    Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The science and practice of medication-assisted treatments for opioid dependence.
    Pecoraro A; Ma M; Woody GE
    Subst Use Misuse; 2012; 47(8-9):1026-40. PubMed ID: 22676570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
    Kampman K; Jarvis M
    J Addict Med; 2015; 9(5):358-67. PubMed ID: 26406300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Favorable mortality profile of naltrexone implants for opiate addiction.
    Reece AS
    J Addict Dis; 2010 Jan; 29(1):30-50. PubMed ID: 20390697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of blood toxicology in fatalities involving alcohol and other drugs in patients with an opioid use disorder treated with methadone, buprenorphine, and implant naltrexone.
    Kelty E; Hulse G; Joyce D
    Am J Drug Alcohol Abuse; 2020; 46(2):241-250. PubMed ID: 31860367
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
    Radomska M; Pach J; Chrostek Maj J
    Przegl Lek; 2001; 58(4):351-3. PubMed ID: 11450367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Agency offers guidance on office-based drug treatment for opioid addiction.
    Mitka M
    JAMA; 2003 Feb; 289(6):690. PubMed ID: 12585931
    [No Abstract]   [Full Text] [Related]  

  • 53. Medication-assisted therapies--tackling the opioid-overdose epidemic.
    Volkow ND; Frieden TR; Hyde PS; Cha SS
    N Engl J Med; 2014 May; 370(22):2063-6. PubMed ID: 24758595
    [No Abstract]   [Full Text] [Related]  

  • 54. Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward.
    Breen CT; Fiellin DA
    J Law Med Ethics; 2018 Jun; 46(2):272-278. PubMed ID: 30147002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Buprenorphine: an alternative to methadone.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):13-5. PubMed ID: 12592214
    [No Abstract]   [Full Text] [Related]  

  • 56. The alternative therapy.
    Hicks M
    Nurs Stand; 2000 Jul 26-Aug 1; 14(45):18. PubMed ID: 11974198
    [No Abstract]   [Full Text] [Related]  

  • 57. A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
    O'Brien CP
    JAMA; 2008 Jul; 300(3):314-21. PubMed ID: 18594026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Buprenorphine: a review.
    Wakhlu S
    J Opioid Manag; 2009; 5(1):59-64. PubMed ID: 19344049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Policy progress for physician treatment of opiate addiction.
    Merrill JO
    J Gen Intern Med; 2002 May; 17(5):361-8. PubMed ID: 12047733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
    Newman RG
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):e142. PubMed ID: 25197828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.